Stocks · Health care · Biological Products, (No Diagnostic Substances)

FENNEC PHARMACEUTICALS INC.

FENC Clue Score47
United States Fiscal year ends December CIK 0001211583 Results filed 24 Mar 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert Andrade
28 Aug 2026
Chief Financial Officer
Exercised, kept
21,928
$5.10
$111.83K
Christiana Marie Cioffi
26 Mar 2026
Chief Strategy Officer
Exercised, kept
4,700
$4.23
$19.88K
Robert Andrade
26 Mar 2026
Chief Financial Officer
Exercised, kept
13,072
$5.10
$66.67K
Robert Andrade
18 Feb 2026
Chief Financial Officer
Exercised, kept
2,450
$4.08
$10.00K
Robert Andrade
23 Jan 2026
Chief Financial Officer
Exercised, kept
10,000
$2.45
$24.50K
Robert Andrade
15 Jan 2026
Chief Financial Officer
Exercised, kept
10,000
$2.45
$24.50K
Robert Andrade
7 Jan 2026
Chief Financial Officer
Exercised, kept
14,184
$2.45
$34.75K
Rosty Raykov
8 Oct 2025
Director
Exercised, kept
4,609
$2.45
$11.29K
Rosty Raykov
5 Sep 2025
Director
Exercised, kept
36,207
$2.45
$88.71K
Robert Andrade
22 May 2025
Chief Financial Officer
Exercised, kept
8,220
$5.10
$41.92K
Rosty Raykov
20 Dec 2024
Director
Exercised, kept
25,000
$2.69
$67.25K
Robert Andrade
18 Nov 2024
Chief Financial Officer
Exercised, kept
15,816
$2.45
$38.75K
Khalid Islam
16 Nov 2023
Director
Exercised, kept
20,492
$2.44
$50.00K
Khalid Islam
16 Nov 2023
Director
Exercised, kept
50,000
$1.13
$56.50K
Khalid Islam
16 Nov 2023
Director
Exercised, kept
10,000
$2.69
$26.90K
Khalid Islam
16 Nov 2023
Director
Exercised, kept
133,333
$2.31
$308.00K
Rosty Raykov
3 Nov 2023
Chief Executive Officer
Exercised, kept
74,793
$1.59
$118.92K
Chris A Rallis
17 Apr 2023
Director
Exercised, kept
1,700
$2.94
$5.00K
Chris A Rallis
3 Mar 2023
Director
Exercised, kept
4,166
$2.40
$10.00K
Chris A Rallis
20 Oct 2022
Director
Exercised, kept
4,762
$1.05
$5.00K
Chris A Rallis
18 Jul 2022
Director
Exercised, kept
11,111
$0.45
$5.00K
Chris A Rallis
8 Mar 2022
Director
Exercised, kept
9,259
$0.54
$5.00K
Chris A Rallis
8 Mar 2022
Director
Exercised, kept
8,333
$0.60
$5.00K
Chris A Rallis
21 Oct 2021
Director
Exercised, kept
3,333
$1.50
$5.00K
Rosty Raykov
13 Aug 2020
Chief Executive Officer
Exercised, kept
323,961
$1.85
$599.33K
Robert Andrade
13 Aug 2020
Chief Financial Officer
Exercised, kept
323,961
$1.85
$599.33K
Rosty Raykov
20 Aug 2018
Chief Executive Officer
Exercised, kept
17,050
$1.44
$24.55K
Robert Andrade
15 Aug 2018
Chief Financial Officer
Exercised, kept
17,050
$1.44
$24.55K

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 36
Sales straight out of an exercise 33
Sales at will 54
Transactions with no price 0
Shares from compensation/vesting 2,375,233
Sales filed before the plan box existed 39
History held since 2 May 2007